Abstract
The surgical treatment outcome in patients with pharmacoresistant epilepsy directly depends on the epileptic focus localization accuracy. Conventional diagnostic algorithms for patients with epilepsy involve starting with video EEG monitoring and magnetic resonance imaging. It is not possible to localize epileptogenic foci with the use of these techniques in a large segment of patients with pharmacoresistant epilepsy, or the test results are discordant. The review provides the analysis of literature data on the current possibilities of SPECT, PET and new hybrid PET-MRI technique when used for preoperative planning in patients with refractory epilepsy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.